DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Generic: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Prasco LaboratoriesManufacturer
ORALRoute
DAPAGLIFLOZIN PROPANEDIOLActive Substance
2014-10-29Original Approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is FDA application NDA205649, sponsored by ASTRAZENECA AB. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HYPOGLYCAEMIA
2 reports
2
ACUTE KIDNEY INJURY
1 reports
3
ASTHENIA
1 reports
4
BLOOD PRESSURE DECREASED
1 reports
5
FATIGUE
1 reports
6
HYPERINSULINAEMIA
1 reports
7
HYPOGLYCAEMIC COMA
1 reports
8
INTENTIONAL OVERDOSE
1 reports
9
LACTIC ACIDOSIS
1 reports
10
METABOLIC DISORDER
1 reports